Optimized dual antimicrobial susceptibility testing improves therapy and reduces costs in hospitalized patients, suggesting better outcomes.
Optimized microbiology workflows, including dual AST cards and faster AST report, significantly accelerated reporting and facilitated timely, precise antimicrobial therapy, particularly carbapenem stewardship, while reducing clinical and economic burdens.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: